Abstract:Rift valley fever virus (RVFV) is the causative agent of a viral zoonosis that causes a significant clinical burden in domestic and wild ruminants. Major outbreaks of the virus occur in livestock, and contaminated animal products or arthropod vectors can transmit the virus to humans. The viral RNA-dependent RNA polymerase (RdRp; L protein) of the RVFV is responsible for viral replication and is thus an appealing drug target because no effective and specific vaccine against this virus is available. The current study reported the structural elucidation of the RVFV-L protein by in-depth homology modeling since no crystal structure is available yet. The inhibitory binding modes of known potent L protein inhibitors were analyzed. Based on the results, further molecular docking-based virtual screening of Selleckchem Nucleoside Analogue Library (156 compounds) was performed to find potential new inhibitors against the RVFV L protein. ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity analysis of these compounds was also performed. Besides, the binding mechanism and stability of identified compounds were confirmed by a 50 ns molecular dynamic (MD) simulation followed by MM/PBSA binding free energy calculations. Homology modeling determined a stable multi-domain structure of L protein. An analysis of known L protein inhibitors, including Monensin, Mycophenolic acid, and Ribavirin, provide insights into the binding mechanism and reveals key residues of the L protein binding pocket. The screening results revealed that the top three compounds, A-317491, Khasianine, and VER155008, exhibited a high affinity at the L protein binding pocket. ADME analysis revealed good pharmacodynamics and pharmacokinetic profiles of these compounds. Furthermore, MD simulation and binding free energy analysis endorsed the binding stability of potential compounds with L protein. In a nutshell, the present study determined potential compounds that may aid in the rational design of novel inhibitors of the RVFV L protein as anti-RVFV drugs.

Host entry factors of Rift Valley Fever Virus infection

Lrp1 is a host entry factor for Rift Valley fever virus

Arm race between Rift Valley fever virus and host

Molecular Biology of Rift Valley Fever Virus

A Mitochondrial Membrane Protein is a Target for Rice Ragged Stunt Virus in Its Insect Vector.

Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis

An LIR motif in the Rift Valley fever virus NSs protein is critical for the interaction with LC3 family members and inhibition of autophagy

Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs

Structural Elucidation of Rift Valley Fever Virus L Protein Towards the Discovery of Its Potential Inhibitors

An immunoinformatic investigation on Rift Valley fever virus protein reveals possible epitopes for vaccines

The increasing threat of Rift Valley fever virus globalization: strategic guidance for protection and preparation

CK1 and PP1 regulate Rift Valley fever virus genome replication through L protein phosphorylation

Rift Valley Fever Virus: An Overview of the Current Status of Diagnostics

Structural insights into Rift Valley fever virus replication machinery

Discovery of Rift Valley Fever Virus Natural Pan-Inhibitors by Targeting Its Multiple Key Proteins Through Computational Approaches

Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya

Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover

LDLR is used as a cell entry receptor by multiple alphaviruses

Packaging of Rift Valley Fever Virus Pseudoviruses and Establishment of a Neutralization Assay Method

Nucleocapsids of the Rift Valley fever virus ambisense S segment contain an exposed RNA element in the center that overlaps with the intergenic region

Structure of Rift Valley fever virus RNA-dependent RNA polymerase